Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The BALANCE Model was designed to expand coverage of GLP-1s for obesity in Medicaid and Medicare Part D According to CMS, the BALANCE Model aims to increase access to GLP-1 medications and healthy lifestyle interventions to help people on Medicare and Medicaid improve their overall health
Medication is not a standalone treatment
Key Features: Offers injectable and oral compounded semaglutide, tirzepatide, and liraglutide
Usually it comes in capsule or liposomal form
US$ 29.59
US$ 25.94
US$ 28.83
US$ 23.92
